{"symbol":"ABT","fiscalQuarter":"Q2-2024","reportDate":"2024-07-18","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q2-2024","postBrief":{"headline":"Abbott Labs Beats on EPS, Stock Down 4.4%","keyNumbers":[{"metric":"EPS","actual":"$1.14","expected":"N/A","surprise":"+3.54%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted the resilience of their product portfolio despite market challenges.","They acknowledged ongoing pressures but expressed confidence in long-term growth strategies."],"summary":"Overall, management conveyed a sense of cautious optimism regarding future performance. They emphasized their commitment to innovation and adapting to market conditions."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Abbott Labs reported a slight earnings beat, which indicates some strength in their operations. However, the stock fell 4.4% in reaction, likely due to the lack of revenue data and guidance. Investors may be concerned about future growth prospects given the current market environment.","metaDescription":"Abbott Labs (ABT) Q2 2024 earnings: EPS beat by 3.54%. Stock down 4.4%. Full breakdown."}}